Ovid Therapeutics Inc. · NASDAQ:OVID

Papadopoulos Stelios received 17,578 Ovid Therapeutics Inc. shares as an award (Form 4)

Traded Apr 7, 2026 · Filed Apr 9, 2026

On Apr 7, 2026, Papadopoulos Stelios (Director) received 17,578 Ovid Therapeutics Inc. shares as an award at US$2.56 for US$45,000, leaving 217,578 shares. Filed Apr 9, 2026 (Form 4).

Awarded
17,578 shares
Price
US$2.56
Value
US$45,000
Holding after
217,578 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 7, 2026Common StockAward17,578US$2.56217,578Direct

Source

View original at SEC

Related